Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul;43(7):1035-1040.
doi: 10.1038/s41587-025-02694-w.

Defining and benchmarking open problems in single-cell analysis

Collaborators, Affiliations

Defining and benchmarking open problems in single-cell analysis

Malte D Luecken et al. Nat Biotechnol. 2025 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: M.D.L. consults for CatalYm GmbH, contracted for the Chan Zuckerberg Initiative and received speaker fees from Pfizer and Janssen Pharmaceuticals. S.G. has equity interest in Immunai Inc. D.B.B. is a paid employee of and has equity interest in NVIDIA. R.C. has equity interest in Data Intuitive BV. L.Z. has consulted for Lamin Labs GmbH. W.L. contracted for Protein Evolution Incorporated. From 2019 to 2022, A.A. was a consultant for 10x Genomics. From October 2023, E.D. has been a consultant for EnsoCell Therapeutics. O.B.B is currently an employee of Bridge Bio Pharma. A.S. consults for Cellarity Inc. and Exvivo Labs Inc. A.B. is a paid employee of and has equity interest in Cellarity, Inc. J.B. has equity interest in Cellarity, Inc. J.S.-R. reports funding from GSK, Pfizer and Sanofi and fees or honoraria from Travere Therapeutics, Stadapharm, Astex, Owkin, Pfizer and Grunenthal. D.W. has equity interest in Immunai Inc. F.J.T. consults for Immunai Inc., Singularity Bio B.V., CytoReason Ltd and Cellarity, and has ownership interest in Dermagnostix GmbH and Cellarity. S.K. is a visiting professor at Meta and scientific advisor at Ascent Bio, Inc. E.d.V.B has ownership interest in Retro Biosciences and ImYoo Inc and is employed by ImYoo Inc. A.T.C. is an employee of Orion Medicines. B.D. is a paid employee of and has equity interest in Cellarity Inc. A.G. is currently an employee of Google DeepMind. Google DeepMind has not directed any aspect of this study nor exerts any commercial rights over the results. R.L. is an employee of Genentech. V.S. has ownership interest in Altos Labs and Vesalius Therapeutics. A.T. has an ownership interest in Dreamfold.

Update of

References

    1. Zappia, L., Phipson, B. & Oshlack, A. PLOS Comput. Biol. 14, e1006245 (2018). - PubMed - PMC
    1. Heumos, L. et al. Nat. Rev. Genet. 24, 550–572 (2023). - PubMed
    1. Luecken, M. D. & Theis, F. J. Mol. Syst. Biol. 15, e8746 (2019). - PubMed - PMC
    1. Donoho, D. J. Comput. Graph. Stat. 26, 745–766 (2017).
    1. Sonrel, A. et al. Genome Biol. 24, 119 (2023). - PubMed - PMC